Study: LTC Residents See Greater Benefit from High-Dose Flu Vaccine

Researchers at the University of Pittsburgh have found that elderly people in long-term care facilities see a greater antibody boost when they receive a high-dose flu vaccine versus a standard vaccine.

The two-year study involved 200 LTC residents between the ages of 86 and 87, all of whom required assistance with many ADLs. During the first year of the study, participants' antibody levels for all three flu strains (A, B and H1N1) were much higher after 30 days if they received the high-dose vaccine. During the second year, participants saw boosted antibody levels against A-strain and B-strain flu, but not H1N1. The researchers explained that this could be because some participants took part in both years of the study, so they were already vaccinated against H1N1 the first year.

To learn more, click here.